MLchartDataset catalogue

Canerpaturev

Term · Oncology and biomedicine · MLC-T-ONC-012223

A non-engineered, naturally oncolytic, replication-competent spontaneous herpes simplex virus (HSV) type I mutant variant. Upon intratumoral injection, canerpaturev transfects, replicates in, and lyses rapidly dividing cells such as tumor cells. In addition, this agent may increase host immune responses that may kill non-infected tumor cells.

Table 1. Record
IdentifierMLC-T-ONC-012223
FieldOncology and biomedicine
Synonymsherpes simplex virus type 1 HF10; HSV1 HF10
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012223",
  "term": "Canerpaturev",
  "field": "Oncology and biomedicine",
  "definition": "A non-engineered, naturally oncolytic, replication-competent spontaneous herpes simplex virus (HSV) type I mutant variant. Upon intratumoral injection, canerpaturev transfects, replicates in, and lyses rapidly dividing cells such as tumor cells. In addition, this agent may increase host immune responses that may kill non-infected tumor cells.",
  "synonyms": [
    "herpes simplex virus type 1 HF10",
    "HSV1 HF10"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/canerpaturev/"
}

Record 4,090 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.